Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Canopy Growth Corp T.WEED

Alternate Symbol(s):  T.WEED.DB | CGC

Canopy Growth Corporation is a cannabis company. It delivers innovative products with a focus on premium and mainstream cannabis brands, including Doja, 7ACRES, Tweed, and Deep Space, in addition to category-defining vaporizer technology made in Germany by Storz & Bickel. The principal activities of the Company are the production, distribution and sale of a diverse range of cannabis and cannabinoid-based products for both adult-use and medical purposes under a portfolio of distinct brands in Canada. Its Canada cannabis segment includes the production, distribution, and sale of a range of cannabis, hemp, and cannabis related products in Canada. International markets cannabis segment includes the production, distribution, and sale of a range of cannabis and hemp products internationally. Storz & Bickel segment includes the production, distribution, and sale of vaporizers. This Works segment includes the production, distribution and sale of beauty, skincare, wellness and sleep products.


TSX:WEED - Post by User

Bullboard Posts
Comment by Kiluminati1984on Feb 08, 2020 9:32pm
107 Views
Post# 30663387

RE:Canopy Growth Corporation (CGC) Expected to Beat Earnings

RE:Canopy Growth Corporation (CGC) Expected to Beat Earnings

From the last ER transcript
Mark Zekulin
 -- Chief Executive Officer

"Yes, I know, totally, and great question. I would say if we park the question for a second and we look at everything else going on in the business, right, our recreational market share is sitting north of 25% across the country, in our view. So gross revenues prior to adjustments, up 6% to $118 million. Canadian medical sales, up; global medical sales, up; retail sales, up, fifth largest retail network; overall cannabis shipments, up."
 

  • September: CA$122.93 million ($93.5 million)
  • October: CA$128.98 million ($98.1 million)
  • November: CA$135.75 million ($103.25 million)


So, if we add 5 mill US onto Dec, take 25%, to be conservative because he clearly said north, we have $77+ M US if our market share held bare min. Estimate is $79.2 M US.
This doesnt include international sales whatsover.

Then this potential:

Vivien Azer -- Cowen and Company -- Analyst

Well, I thought you were going to -- you would have recognized some revenue in 3Q, but if it's 4Q, then yes, any commentary in the back half on revenue generation expectations for U.S. CBD, please?

Mark Zekulin -- Chief Executive Officer

Yes. I think our target remains Q4 of this fiscal. While it is potential, some of that might creep into Q3. I don't think there'll be anything material in Q3, to be quite honest.

I think we could beat. The shorts have straight up become complacent, imagine if we were to beat coupled with a stellar news release?
Call me a dreamer but sooner or later its gonna happen.
Can you say SQUEEZE?

Bullboard Posts